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Introduction
The plasma membrane is highly dynamic and crucial for com-
munication of cells with their environment. It transduces nu-
merous extracellular signals and transports molecules in and out 
of the cell. To accommodate these diverse tasks, it is highly or-
ganized, and plasma membrane processes are tightly coordi-
nated, both spatially and temporally (Simons and Toomre, 2000; 
Anderson and Jacobson, 2002; Simons and Vaz, 2004). How the 
abundance of most lipids and proteins in the plasma membrane 
is regulated is largely unknown.
In the yeast Saccharomyces cerevisiae, the plasma mem-
brane is laterally organized into spatial domains that have dif-
ferent  protein  and  lipid  composition.  One  type  of  domain 
harbors several integral membrane proteins, such as the argi-
nine transporter Can1 and members of the Sur7 family of pro-
teins and was accordingly termed membrane compartment 
occupied by Can1 (MCC). MCCs were suggested to contain a 
distinct lipid composition enriched in ergosterol, as visualized 
by staining with filipin, a fluorescent marker binding this lipid 
(Malinska et al., 2003; Grossmann et al., 2007).
Yeast mother cells possess 25–45 MCCs that can be visual-
ized as discrete foci in the plasma membrane. MCCs are mutually 
exclusive with a second domain, marked by the plasma membrane 
ATPase Pma1, termed membrane compartment occupied by Pma1 
(MCP; Malinska et al., 2003, 2004). The organization of the plasma 
membrane in distinct spatial domains is at least in part mediated by 
large protein complexes termed eisosomes (Walther et al., 2006). 
Eisosomes lie underneath each MCC forming a punctate, distrib-
uted pattern in the cell cortex. When the gene encoding the major 
eisosome component Pil1 is deleted, MCCs and all remaining eiso-
some proteins investigated so far coalesce into one or a few punctae 
per cell (Walther et al., 2006; Grossmann et al., 2007). In addition 
to concentrating at such eisosome remnants, a significant fraction 
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of MCC transmembrane proteins, such as Sur7, localizes uniformly 
in the plasma membrane. Similarly, the ergosterol marker filipin 
looses its normal punctate eisosome localization in pil1 cells, dis-
tributes more evenly over the plasma membrane surface, and en-
riches at eisosome remnants (Grossmann et al., 2007).
One possible function of MCCs and eisosomes is to regu-
late protein and lipid abundance by sorting them into distinct, 
spatially separated pools where they are stabilized or from which 
they can be endocytosed selectively. Consistent with this notion, 
disruption of MCCs leads to increased turnover of some proteins 
normally localized there (Grossmann et al., 2008). The precise 
molecular function of eisosomes is still unclear, but it was sug-
gested that they regulate sites of endocytosis based on their   
colocalization with endocytic intermediates visualized by the   
lipophilic dye FM4-64 and a hexose transporter GFP fusion pro-
tein (Walther et al., 2006). A clue of how eisosomes might be reg-
ulated is provided by the discovery that Pkh kinases localize at 
eisosomes and that Pil1 and Lsp1 are Pkh kinase substrates 
(Zhang et al., 2004; Walther et al., 2007; Luo et al., 2008).
Pkh kinases regulate physiology and plasma membrane 
functions such as actin patch organization, endocytosis, and 
eisosome assembly (Inagaki et al., 1999; Sun et al., 2000; Friant 
et al., 2001; deHart et al., 2002; Liu et al., 2005; Grosshans et al., 
2006; Daquinag et al., 2007; Walther et al., 2007; Luo et al., 
2008). These responses are mediated by their targets, including 
Ypk1 and Ypk2 (homologues of the mammalian serum gluco-
corticoid kinase), Sch9 (homologue of human AKT kinase), 
Pkc1 (atypical protein kinase C), and myosin-I. In addition, Pkh 
kinase phosphorylation of Pil1 regulates the assembly state of 
eisosomes (Walther et al., 2007; Luo et al., 2008).
Pkh kinases are regulated by sphingoid long chain bases such 
as phytosphingosine (PHS) and dihydrosphingosine, which are 
precursors in sphingolipid synthesis (Zhang et al., 2004). However, 
it is not known how Pkh kinases sense and respond to long chain 
bases. Pkh kinases and several other kinases of the signaling mod-
ule are regulated by levels of long chain bases in vitro, but whether 
this is relevant in vivo and whether it is the only way to control Pkh 
kinase activity is not clear (Zhang et al., 2004; Liu et al., 2005).
In this study, we visually screened for genes that affect 
eisosome organization either directly or through altering Pkh ki-
nase activity. We identified the transmembrane protein Nce102 
as part of the sphingolipid–Pkh signaling network. Our func-
tional experiments suggest that Nce102 might act as a sphingo-
lipid sensor that modulates Pkh kinase activity to regulate plasma 
membrane organization and function.
Results
Nce102 is required for normal  
eisosome organization
To identify genes required for eisosome assembly and organi-
zation, we screened by fluorescence microscopy a systematic 
gene deletion collection into which we introduced GFP-labeled 
Figure 1.  A functional genomic screen reveals genes required for eiso-
some organization. (a) Genes with a Pil1 organization phenotype shown 
in functional groups. (b) Nce102 is required for normal eisosome orga-
nization. Images of Pil1-GFP expressed in wild-type (wt; left) or nce102 
cells (right) are shown. (c) Number of eisosomes per mother cell (left), 
cytoplasmic Pil1-GFP fluorescence (middle), and Pil1-GFP fluorescence per 
eisosome (right). Error bars indicate SD. Bar, 5 µm.
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(MAK3,  MAK10,  and  MAK31)  showed  a  similar  phenotype 
characterized  by  fewer  eisosomes,  increased  cytoplasmic   
Pil1-GFP, and little change in the size of remaining eisosomes.
In  addition,  several  hits  (YMR031C,  YMR086W,  and 
MSC3) are good candidates for genes encoding previously 
not recognized eisosome components because they localize 
in a punctuate pattern at the cell periphery similar to eiso-
somes, and at least Ymr031c and Ymr086c were copurified 
with Pil1 (Huh et al., 2003; Grossmann et al., 2008; Deng   
et al., 2009).
In this study, we focused on Nce102 because it is the 
only hit in our screen previously found as a transmembrane 
plasma membrane protein (Cleves et al., 1996). To confirm 
the role of Nce102 in eisosome formation, we investigated 
the  localization  of  Pil1-GFP  in  nce102  compared  with 
wild-type  cells.  Consistent  with  the  systematic  genome-
wide screen, confocal images showed a clear reduction of 
Figure 2.  NCE102 is required for normal plasma membrane organization. (a and b) Sur7-GFP (a) and Pma1-GFP (b) were expressed in wild-type (wt) or 
nce102 cells, and representative confocal top (bottom) and mid sections (top) are shown. (c) Wild-type and nce102 cells expressing Pil1-GFP (green) 
were pulse labeled with FM4-64 (red) for 1 min, and representative images are shown. Boxes indicate the area magnified in the bottom panels. (d) Num-
bers of FM4-64 intermediates per cell (n > 50) from images as in c are shown as a histogram. Bars, 5 µm.
Pil1 fusion protein (Pil1-GFP; Fig. S1 a; Tong et al., 2001). 
To determine the effect of individual mutations on eisosomes, 
we grew the library in 96-well plates to mid-log phase and 
imaged cells with an automated microscope. Visual inspec-
tion of the images led to identification of 88 genes that affect 
eisosomes (Fig. 1 a).
To obtain quantitative data for the identified mutants, 
we collected confocal images and quantitated the number   
of eisosomes per cell, the cytosolic fluorescence signal rep-
resenting  unassembled  Pil1-GFP,  the  integrated  fluores-
cence on the cell surface, the size of individual eisosomes, 
and the percentage of cell surface covered with eisosomes   
(Fig. S1 a). The relative values for these parameters were 
used to cluster the genes according to the similarity of their 
phenotypes (Fig. S1 b).
For example, deletion of genes encoding subunits of the 
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Nce102 is required for membrane 
organization
Eisosomes organize MCCs, and mutation of PIL1 results in 
mislocalization of all tested MCC components (Walther et al., 
2006; Grossmann et al., 2007, 2008). Because NCE102 deletion 
eisosome number and a wider spacing of remaining eiso-
somes  (Fig.  1  b).  Quantitation  revealed  that  deletion  of 
NCE102 results in a twofold decrease of eisosome number 
per  mother  cell  and  concomitant  increase  of  cytosolic   
signal (Fig. 1 c).
Figure 3.  Nce102 localizes to both MCC and non-MCC domains in the plasma membrane. (a) Images from cells expressing Nce102-GFP (left; green 
in overlay) and Sur7-mars (middle; red in the overlay) are shown. (b) Intensity profiles of Nce102-GFP and Sur7-mars along the plasma membrane.   
(c) Images from cells expressing Nce102-GFP (left; green in overlay) and Lsp1-mars (middle; red in the overlay) are shown. Boxes indicate the area magnified 
in the bottom panels. (d) Intensity profiles of Nce102-GFP and Lsp1-mars along the plasma membrane. (e) Pil1 is required for normal Nce102 distribution. 
Wild-type (left) and pil1 (right) cells expressing Nce102-GFP are shown. Arrows highlight eisosome remnants. Bars, 5 µm.1231 NCE102 MEDIATES SPHINGOLIPID SIGNALING • Fröhlich et al.
the architecture, assembly, or stability of eisosomes and genes in-
volved in signaling that modifies Pil1 phosphorylation. In fact, 
the nce102 phenotype on Pil1-GFP localization closely re-
sembles the phenotype of pil1(4D) mutant cells, bearing a 
phosphomimicking mutant of Pil1-GFP in which four residues 
that are phosphorylated in the wild-type protein are mutated to 
aspartate (S45D, S59D, S230D, and T233D; Fig. 1 b and Fig. S4 
c; Walther et al., 2007).
Therefore, we tested genetically whether Nce102 acts on 
eisosomes by altering Pil1 phosphorylation that could then indi-
rectly modulate eisosome assembly. If nce102 effect is medi-
ated by phosphorylation, we expect that a pil1(4A)-GFP mutant 
in which four residues that are required for the effect of Pkh   
kinases on eisosome assembly are changed to alanine (S45A, 
S59A, S230A, and T233A; Walther et al., 2007) blocks the effect 
of NCE102 deletion. However, if Nce102’s effect on eisosomes   
is independent of Pil1 phosphorylation state, we expect to see 
similar effects of nce102 on wild-type Pil1 and pil1(4A).   
has a strong effect on eisosomes, we asked whether NCE102 is 
also required for plasma membrane organization. Indeed, com-
pared with wild-type cells in which the MCC marker Sur7-GFP 
was organized in distinct domains, nce102 cells showed only 
few clusters and more uniform localization of Sur7-GFP through-
out the plasma membrane (Fig. 2 a). Furthermore, we observed a 
consistent but less pronounced phenotype on the MCP marker 
Pma1, which localized more uniformly in nce102 cells com-
pared with its normal localization in structured plasma membrane 
domains (Fig. 2 b).
Next, we asked whether Nce102 influences the formation 
of endocytic intermediates formed as foci at eisosomes by using 
the lipophilic tracer FM4-64 (Vida and Emr, 1995; Walther et al., 
2006). FM4-64 foci formed after short chase periods of 1 min 
and colocalized with eisosomes in both wild-type and nce102 
cells (Fig. 2 c). However, when we quantitated the number of 
foci, we found their number greatly reduced in nce102 cells 
(median = 1 foci/cell; Fig. 2 d, right) compared with wild-type 
cells (median = 4 foci/cell; Fig. 2 d, left). Together, this shows 
that normal plasma membrane organization requires Nce102.
Nce102 localizes to the plasma membrane 
at MCC
To answer how Nce102 functions, we first investigated its sub-
cellular localization. In agreement with a recent study that iden-
tified Nce102 as an MCC component, we found Nce102-GFP 
localizing in the plasma membrane and accumulating in foci 
reminiscent of MCCs (Fig. 3 a; Grossmann et al., 2008). This 
notion was further confirmed by colocalization of Nce102 with 
plasma membrane markers but not, for example, with cortical 
ER markers (unpublished data).
To test whether Nce102 foci are MCCs, we investigated 
their localization in respect to Sur7 tagged with the red fluoro-
phore RFP-mars (Fischer et al., 2004), an MCC marker. Nce102 
foci completely overlapped with Sur7-marked MCCs (Fig. 3,   
a and b) with significant levels of Nce102-GFP also diffusely 
localized in the remainder of the plasma membrane. As MCCs 
are membrane domains located over eisosomes, we addition-
ally investigated Nce102-GFP localization in respect to eiso-
somes marked by Lsp1-mars and found that Nce102-GFP foci 
and eisosomes colocalize perfectly (Fig. 3, c and d). Because 
Nce102 is a multipass transmembrane domain protein, it is 
most likely located in the MCC and partially in the remainder 
of the membrane.
One hallmark of proteins localizing to eisosomes or MCCs 
is that they collapse to one or a few eisosome remnants in pil1 
cells (Walther et al., 2006; Grossmann et al., 2007). Indeed, 
Nce102-GFP localization in pil1 cells also closely resembles 
that of MCC proteins such as Sur7. Most of Nce102-GFP localizes 
to one or a few eisosome remnants in pil1 cells, whereas the 
remaining portion shows a uniformly distributed signal through-
out the plasma membrane (Fig. 3 e).
Nce102 acts negatively on Pil1 
phosphorylation
Because eisosome organization is sensitive to Pil1 phosphoryla-
tion, we expected to find genes in our screen that directly affect 
Figure 4.  Nonphosphorylatable Pil1 is resistant to nce102 . (a and b) 
Representative top and mid sections of wild-type (wt; left) or nce102 cells 
(right) expressing Pil1-GFP (a) or nonphosphorylatable pil1(4A) fused to 
GFP (b) are shown. Bars, 5 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1232
Indeed, pil1(4A)-GFP localization was indistinguishable between 
nce102 and wild-type cells, showing slightly more eisosome 
pil1(4A) assembly at the plasma membrane compared with wild-
type Pil1 (Fig. 4 b). Therefore, pil1(4A) is epistatic to nce102. 
Because Pil1 needs to get phosphorylated on residues mutated in 
pil1(4A) to develop the nce102 eisosome phenotype, we con-
clude that Nce102 acts upstream of Pil1 phosphorylation.
When  combined  with  pil1(4D)-GFP,  nce102  cells 
showed a similar, albeit slightly more severe phenotype than 
NCE102 pil1(4D)-GFP cells (Fig. S4 c), indicating that phos-
phorylation at additional sites can enhance eisosome disassembly. 
Previous work identified at least seven additional phosphoryla-
tion sites in Pil1, which may mediate this effect (Zhang et al., 
2004; Walther et al., 2007; Luo et al., 2008). Together, pil1(4A) 
epistasis on nce102 and enhancement of the pil1(4D) pheno-
type  by  nce102  suggest  that  Nce102  negatively  regulates 
Pil1 phosphorylation.
Nce102 inhibits Pil1 phosphorylation
To substantiate these findings, we determined whether the phos-
phorylation state of Pil1 is altered in nce102 cells. To this end, 
we purified Pil1 fused to a tandem affinity purification (TAP) tag 
from wild-type and metabolically heavy lysine-labeled nce102 
cells (stable isotope labeling by amino acids in cell culture [SILAC]; 
Fig. S2 a; Ong et al., 2002) and analyzed it by two strategies. First, 
we mixed proteins of Pil1-TAP eluates 1:1 and separated them by 
SDS-PAGE, resulting in a clearly visible doublet of Pil1, where 
the upper band represents phosphorylated Pil1 (Walther et al., 
2007). Separate analysis of the two bands by liquid chromatogra-
phy (LC) mass spectrometry (MS)/MS revealed that contaminant 
proteins present in both bands have a 1:1 ratio of protein from   
wild-type and nce102 sample, as determined by comparing mean 
peptide peak intensities. In contrast, Pil1 from nce102 was 
30% enriched in the upper phospho-Pil1 band (1.28 ratio, Pil1 
heavy vs. light) and correspondingly decreased in the lower band 
(0.59 ratio, Pil1 heavy vs. light; Fig. 5 a; and Fig. S2, c and d).
In a second approach, we directly mixed, digested, and 
analyzed Pil1 pull-down eluates by LC-MS/MS (Fig. S2 a). From 
this approach, we identified many unphosphorylated peptides 
and, for example, the phosphorylated peptide harboring T233 of 
Pil1 from both wild-type and nce102 cells. Importantly, the 
phosphopeptide was more than threefold more abundant com-
ing from the heavy lysine-labeled nce102 samples compared 
with the wild-type control (Fig. 5 b; and Fig. S2, e and f). The 
total amount of Pil1 was equal in both experiments because   
unphosphorylated peptides were present in a 1:1 ratio (Fig. S2 f). 
Together, these data demonstrate that Pil1 was present in a 
roughly equimolar ratio in both pull-down eluates but that   
phosphorylation at T233 was more than threefold increased in 
Figure 5.  Pil1 phosphorylation is increased in nce102 cells. (a) Pil1-TAP 
was purified from SILAC-labeled wild-type and nce102 cells, mixed in 
equal amounts, resolved by SDS-PAGE, and two resulting Pil1 bands were 
separately analyzed by MS. The contaminant Nsr1 was present in a 1:1   
ratio from both strains in each band. Pil1 was1.3-fold enriched in the   
upper band (red) and decreased to a ratio 0.6 in the lower band (black). 
(b) Pil1-TAP purified from SILAC-labeled wild-type and nce102 cells was 
analyzed by MS. Unphosphorylated Pil1 peptide amino acids 222–248 is 
shown in black, and the T233 phosphopeptide is shown in red. (c) Pil1-TAP 
purified from SILAC-labeled untreated cells or treated with myriocin for 1 h 
was analyzed as in b. Representative data of three experiments are shown. 
Ratio H/L denotes the mean ratio of the abundance of heavy- versus light-
labeled peptides.
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on Pil1 phosphorylation occurs through the Pkh kinase path-
way. First, we determined the epistatic relationship between 
Pkh kinase mutants and nce102 using a yeast strain that har-
bors a deletion of PKH2 and a temperature-sensitive allele of 
PKH1 (pkh
ts; Friant et al., 2001). Already at the permissive tem-
perature, these mutations lead to a strong over-assembly effect 
on eisosomes. Specifically, pkh
ts strains display large elongated 
threads of Pil1 at the plasma membrane with more of the mem-
brane covered with Pil1 (Fig. 6; Walther et al., 2007). This 
phenotype is also very severe at the restrictive temperature, with 
most of the membrane covered with Pil1 (Fig. S4 e).
Combining pkh
ts and the nce102 mutations, we found 
that double-mutant cells show a Pil1-GFP phenotype indistin-
guishable from the pkh
ts phenotype at both 24 (Fig. 6) and 37°C 
(Fig. S4 e). This indicates that Pkh kinases are required to   
obtain the nce102 phenotype and shows that Nce102 acts   
upstream of Pkh kinases, inhibiting them in a linear pathway.
Nce102 acts downstream of long chain 
bases in sphingoid base signaling
Our data suggest that Nce102 acts on Pil1 phosphorylation by 
inhibiting Pkh kinases. Because Pkh kinases are regulated by 
sphingoid bases and both, a block of sphingolipid synthesis and 
nce102, lead to increased Pil1 phosphorylation, Nce102 itself 
may be controlled by sphingolipids, acting upstream of the Pkh 
kinases. Alternatively, Nce102 could be required for efficient 
synthesis of sphingolipids that are then sensed by the kinases by 
some other route. One more possibility is that Nce102 acts in-
dependently of sphingolipids to regulate Pkh kinases.
To distinguish between these possibilities, we tested whether 
Nce102 is required for the synthesis of sphingoid bases. If this 
was the case, addition of exogenous sphingoid base would rescue 
the nce102 phenotype. Exogenously added sphingoid bases can 
enter the cell and rescue a sphingoid base synthesis defect be-
cause addition of 5 µM PHS suppressed the Pil1-GFP phenotype 
of the lcb1-100 mutant (which impairs sphingolipid synthesis) 
both at the permissive and restrictive temperatures (Fig. 7 a).   
In contrast, the eisosome defect of nce102 cells was not rescued 
by addition of PHS under conditions that rescued the lcb1-100 
mutant phenotype (Fig. 7 a) or by a 10-fold higher concentration 
of PHS (unpublished data). Quantitation of eisosome number and 
cytosolic Pil1 levels confirmed the visual evaluation (Fig. 7 b).
These data show that Nce102 is not required for sphingoid 
base synthesis but rather acts downstream of it. Because PHS has 
no additive effect on nce102 cells, sphingolipids and Nce102 
act in the same pathway (Fig. 7 b).
To further test this hypothesis, we investigated the inter-
action between myriocin treatment and nce102. If both act inde-
pendent from each other, we expect an additive effect between 
them. However, this is not the case. As shown in images and quan-
titation of eisosomes, myriocin has no further effect on eisosomes 
in  nce102  cells,  confirming  that  sphingolipid  signaling  and 
Nce102 act in the same pathway on eisosomes (Fig. 7, c and d).
We previously showed that Pil1 hyperphosphorylation 
caused by decreased sphingolipid synthesis causes eisosome dis-
assembly (Walther et al., 2007). If our hypothesis is true and 
Nce102 is an inhibitor of Pil1 phosphorylation acting downstream 
nce102 cells. Therefore, the results of the two biochemical 
approaches converge, demonstrating that Pil1 phosphorylation 
is increased in nce102 cells.
Because Pil1 phosphorylation is inhibited by sphingoid 
bases (Zhang et al., 2004; Walther et al., 2007), we tested whether 
NCE102 deletion results in a similar effect on Pil1 phosphoryla-
tion as sphingolipid depletion. To this end, we measured the rela-
tive abundance of the Pil1 T233 phosphopeptide in cells where 
synthesis of sphingolipids was blocked for 1 h by myriocin, a 
drug targeting the serine palmitoyl transferase that catalyzes the 
rate-limiting step of sphingolipid synthesis, compared with wild-
type cells. In this experiment, we detected a twofold increase of 
Pil1 phosphorylation at T233 after myriocin treatment compared 
with wild-type cells (Fig. 5 c and Fig. S2 g). This shows that the 
block of sphingolipid synthesis by myriocin and NCE102 dele-
tion has a similar effect on Pil1 phosphorylation.
Nce102 acts on Pil1 via Pkh kinases
Several studies show that Pil1 phosphorylation is mediated by 
Pkh kinases (Zhang et al., 2004; Walther et al., 2007; Luo   
et al., 2008). Therefore, we asked whether the effect of Nce102 
Figure 6.  Mutation of Pkh kinases is epistatic to nce102. Optical top 
and mid sections of wild-type (wt; top left), nce102 (top right), pkh
ts (bot-
tom left), or pkh1
ts nce102 (bottom right) cells expressing Pil1-GFP are 
shown. Bars, 5 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1234
Figure 7.  Nce102 and sphingolipids act in the same pathway. (a) lcb1-100 but not nce102 is suppressed by sphingoid bases. Wild-type (wt), lcb1-100, 
or nce102 cells expressing Pil1-GFP were analyzed with or without addition of 5 µM PHS, and representative images are shown. (b) Eisosome number per 
mother cell (left) and cytosolic Pil1-GFP fluorescence (right) are shown. (c) Myriocin has no additive effect on nce102 cells. Wild-type and nce102 cells 
were treated for 1 h with 5 µM myriocin, and representative images are shown. (d) Quantitation of eisosome number per mother cell (left) and cytoplasmic 
Pil1-GFP fluorescence (right) of cells treated as in c. Error bars indicate SD. Bars, 5 µm.1235 NCE102 MEDIATES SPHINGOLIPID SIGNALING • Fröhlich et al.
of sphingolipids, we predict that overexpression of Nce102 will 
rescue eisosome disassembly when sphingolipid synthesis is de-
creased. To test this, we expressed Nce102-mars from the induc-
ible Gal promoter in cells that have Pil1-GFP–marked eisosomes. 
When these cells are grown on raffinose, Nce102-mars is not ex-
pressed, and eisosomes appear normal, as these cells also express 
endogenous Nce102 (Fig. 8). When these cells grow on galac-
tose, Nce102-mars is overexpressed (Fig. 8). Strikingly, when we 
blocked sphingolipid synthesis in these cells by treating them with 
myriocin, the normal effect of disassembling eisosomes apparent 
in control cells was completely blocked (Fig. 8). This shows that 
increasing Nce102 levels blocks the effect of inhibiting sphingo-
lipid synthesis on eisosomes.
Together, our genetic experiments thus place Nce102 in a 
linear pathway inhibiting Pkh kinases and suggest a relation-
ship: sphingoid bases → Nce102–| Pkh1/2 → Pil1 phosphoryla-
tion → eisosome disassembly. In this scenario, Nce102 would 
function as part of a sensor relay for sphingoid base or sphingo-
lipid levels.
Nce102 localization responds to changes 
in sphingolipid levels
Because Nce102 negatively regulates Pkh kinases that localize to 
eisosomes, we next tested whether Nce102 distribution between 
MCCs at eisosomes and the rest of the plasma membrane is af-
fected by sphingolipid levels. To this end, we determined Nce102-
GFP localization after blocking sphingolipid synthesis. Strikingly, 
after a 1 h incubation of cells with myriocin, the punctate pattern   
of Nce102-GFP localization in MCCs disappeared, and the pro-
tein distributed diffusely across the plasma membrane (Fig. 9 a). 
Consistently, in intensity plots of surface images, myriocin-
treated cells show a rather flat distribution of the Nce102-GFP 
signal, whereas control samples show many Nce102-GFP peaks 
corresponding to MCCs at eisosomes (Fig. 9 b). Relocalization of 
Nce102-GFP could be reversed by addition of exogenous PHS   
for a short time (15 min). In this case, the MCC pattern of Nce102-
GFP localization reappeared, showing an even more pronounced 
pattern of Nce102-GFP foci than normal (Fig. 9 b).
Nce102 relocalization could be caused by redistribution of 
existing protein in the plasma membrane or new protein synthesis 
under conditions in which myriocin blocks the efficient incorpo-
ration of Nce102 in MCCs. To distinguish these possibilities,   
we added myriocin after a preincubation with the translation-
blocking drug cycloheximide. During persistent translation block, 
Nce102 localized normally to MCCs and the remainder of the 
membrane (Fig. 9 c). Moreover, it still relocalized from MCCs 
after myriocin treatment, indicating that this phenomenon is not 
dependent on protein synthesis (Fig. 9 c). Similarly, when PHS 
was added to cells in which translation was blocked, Nce102   
relocalization occurred normally (Fig. 9 c).
To test whether this effect is specific to the availability of 
sphingoid bases or a more general response to sphingolipid lev-
els, we added aureobasidin to cells for 1 h. This drug inhibits 
complex sphingolipid synthesis from ceramide downstream of 
the formation of sphingoid bases (Nagiec et al., 1997). We ob-
served the same Nce102-GFP redistribution in the plasma 
membrane after aureobasidin or myriocin addition (Fig. 9 a and 
Fig. S4). Consistent with the downstream block of sphingolipid 
synthesis by aureobasidin, addition of exogenous sphingoid 
bases did not result in reformation of the punctate Nce102 
pattern (Fig. S4).
Together, these data suggest an equilibrium of two pools 
of Nce102-GFP localizing to MCCs at eisosomes or to spaces in 
between that is shifted by levels of sphingolipids. Consistent 
with this notion, addition of PHS to untreated cells shifted more 
Nce102-GFP into punctate structures, rendering them more pro-
nounced (Fig. 9, a and b).
In the yeast plasma membrane, many proteins are sensitive 
to extraction by detergents to a different level, and Nce102 was 
previously described operationally as an abundant component of 
detergent-resistant  membranes  (Bagnat  et  al.,  2000).  To  test 
whether Nce102 distribution between MCCs and the remainder 
Figure 8.  Overexpression of Nce102 suppresses eisosomes disassembly 
after sphingolipid synthesis block. Nce102-mars (right) controlled by the 
Gal promoter was either not expressed in raffinose-containing medium or 
induced in galactose-containing medium in Pil1-GFP (left) cells, which were 
incubated for 1 h with 5 µM myriocin as indicated. Bar, 5 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1236
proteins embedded in mostly phospholipid bilayers. This differ-
ence can be tested in a velocity sedimentation gradient. Nce102 
from untreated cells was present in most fractions of the gradi-
ent, indicating that it is localized both to detergent-resistant and 
other membranes (Fig. 9 d). When treated with myriocin, Nce102 
of the plasma membrane observed by microscopy is reflected in 
its partitioning between different membrane environments, we 
analyzed its solubility in a buffer containing 1% Triton X-100   
at  4°C.  Proteins  partitioning  into  sphingolipid/ergosterol-rich 
domains show lower solubility in this buffer compared with   
Figure 9.  Nce102-GFP localization depends 
on sphingolipid levels. (a) Nce102-GFP was 
imaged under normal growth conditions (con-
trol), after addition of 5 µM myriocin for 1 h 
(myriocin), after sequential treatment with 5 µM 
myriocin for 1 h and 50 µM PHS for 15 min 
(myriocin→PHS), or after addition of 50 µM 
PHS for 15 min (PHS). Boxes indicate the area 
magnified in the bottom panels. (b) Fluores-
cence intensities of the area are shown plot-
ted against xy image coordinates. (c) Nce102 
redistribution is not dependent on new protein 
synthesis.  Nce102-GFP  cells  were  treated 
with  myriocin  or  myriocin  and  PHS  succes-
sively as in a after 10-min preincubation and 
continued presence of cycloheximide (CHX). 
(d) Nce102 partitions into detergent-resistant 
membranes  dependent  on  sphingoid  bases. 
Untreated Nce102-TAP–expressing cells and 
cells treated as in a were lysed in buffer con-
taining  1%  Triton  X-100  and  analyzed  by 
gradient centrifugation and Western blotting 
against TAP (left). The same blots were probed 
with Pma1 antibodies (right). (e) pil1(4A)-GFP 
is resistant to disassembly after myriocin treat-
ment.  pil1(4A)-GFP–expressing  cells  were 
imaged after 1-h 5 µM myriocin incubation. 
(f) Redistribution of Nce102-GFP after myrio-
cin  treatment  is  independent  of  eisosome 
disassembly.  Cells  expressing  pil1(4A)  and 
Nce102-GFP were imaged before (left) and 
after 1 h treatment with 5 µM myriocin (right). 
(g  and  h)  Sur7-mars  does  not  behave  like 
Nce102  after  myriocin  treatment.  Wild-type 
Pil1 (g) or pil1(4A) (h) cells expressing Sur7-
mars were treated with myriocin and imaged. 
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affecting Pil1 localization (n = 88). It remains to be seen whether 
this difference is caused by different thresholding during the 
screen or biological differences between MCCs versus eiso-
somes. Because Pil1 and MCC components colocalize and PIL1 
is required for normal MCC formation, it is surprising that there 
is little overlap between the two screens: only NCE102, SUR4, 
MNN10, and few biological processes were found in both.   
Examples include retrograde transport from the Golgi apparatus   
to the ER (VPS52 and VPS54 in the MCC screen; VPS51 and 
VPS53 in the Pil1 screen). Therefore, these genes and processes 
likely have a global effect on plasma membrane organization af-
fecting MCCs and eisosomes. Genes that were identified only in 
one screen likely perform more specific functions; future exper-
iments will, for example, show whether YMR086W, YMR031C, 
or genes encoding the NatC complex are important for eiso-
somes but not MCCs.
Besides genes globally affecting the plasma membrane, we 
expected to find genes impacting eisosome organization directly 
as well as genes that alter sphingolipid signaling, resulting in   
altered Pil1 phosphorylation and assembly. In the later class, we 
identified Nce102. Besides it, also SUR4, ISC1, and SAC1 are 
likely to act on eisosomes through sphingolipid signaling. Dele-
tion of SUR4, required for fatty acid elongation during sphingo-
lipid synthesis (Han et al., 2002; Paul et al., 2006), or deletion of 
ISC1, the homologue of mammalian neutral sphingomyelinase 
(Sawai et al., 2000), results in accumulation of complex sphingo-
lipids. In our screen, both isc1 and sur4 cells showed hyper-
assembled Pil1-GFP, which is the opposite effect of depleting 
complex sphingolipids by inhibiting their synthesis (Table S2). 
In addition, it was recently reported that sac1 cells have ele-
vated sphingoid bases and reduced levels of complex sphingolipids 
(Brice et al., 2009), and we found them to have fewer eisosomes 
and increased cytoplasmic Pil1-GFP signal (Table S2). We ex-
pect that other genes indentified will also turn out to play a role 
in sphingolipid biology.
In this study, we focused on the function of Nce102, a multi-
spanning plasma membrane protein required for normal eiso-
somes, MCC formation, and plasma membrane organization. 
Initially, Nce102 was identified by Cleves et al. (1996) as re-
quired for nonclassical export of mammalian galectin from yeast. 
The mechanism of Nce102 function in this pathway was not in-
vestigated. Because the assay used requires solubilization of cell-
associated galectin using high pH, it is possible that the basis of 
the effect could be altered protein extractability from nce102 
cells because of their altered plasma membrane.
Our experiments revealed that Nce102 has fascinating 
properties, suggesting that it might act as part of a sphingolipid 
sensor. Most remarkable, its localization is dynamic and respon-
sive to changes in sphingolipid levels: Nce102 partitions between 
two domains in the plasma membrane, MCCs overlying eiso-
somes and the rest of the plasma membrane. We show that the 
distribution between these two domains is controlled by sphin-
golipid availability. Nce102 localization to MCCs brings it into 
close contact with the underlying eisosomes and Pkh kinases 
(Fig. S5; Walther et al., 2007). Nce102 negatively regulates the 
activity of these kinases, and, in the presence of sphingolipids, 
blocks their downstream functions. Conversely, if sphingolipid 
partitioning changed toward the bottom of the gradient, indicat-
ing higher solubility. After short treatment of these cells with 
PHS, Nce102 redistributed to more detergent-insoluble mem-
brane fractions at the top of the gradient. Pma1, a marker for 
MCP membranes, did not significantly alter its migration in the 
gradient after either myriocin or PHS treatment.
Together, these results show that relative levels of Nce102 in 
different plasma membrane domains are regulated by sphingo-
lipids and that this redistribution is highly sensitive to changes in 
membrane composition because it can be observed after small 
perturbations that do not change Pma1 behavior. These data are 
consistent with the hypothesis that Nce102 sphingolipid-mediated 
redistribution is the mechanism by which Nce102 regulates Pil1 
phosphorylation. In this model, Nce102 is recruited to MCCs at 
eisosomes under conditions of sufficient sphingolipids to repress 
Pkh kinase activity toward Pil1 and released from there when 
sphingolipid levels drop, for example, after inhibition of their syn-
thesis by myriocin or aureobasidin. To test this, we determined the 
localization of Nce102-mars relative to Pkh kinases. Pkh2-GFP 
localizes in few very dim spots that colocalize with eisosomes and 
Nce102 foci (Fig. S5, a and b). Importantly, when we blocked 
sphingolipid synthesis with myriocin, Nce102-mars relocalized 
from these foci, leaving Pkh2-GFP behind (Fig. 5, c and d).
If Nce102 acts as a plasma membrane sphingolipid sen-
sor, then its partitioning should be upstream and independent of 
the assembly state of eisosomes. Alternatively, Nce102 redistri-
bution could be a consequence of eisosome disassembly after 
inhibition of sphingolipid synthesis. To test this directly, we 
used pil1(4A) mutant cells in which Pil1 cannot be sufficiently 
phosphorylated. Eisosomes are therefore resistant to activation 
of Pkh kinases (Walther et al., 2007). As expected, when cells 
that express pil1(4A)-GFP as their sole copy of Pil1 are incu-
bated with myriocin, eisosomes remain stable because Pil1(4A) 
does not get sufficiently phosphorylated to disassemble (Fig. 9 e). 
To determine whether Nce102-GFP redistribution is caused by 
disassembly of eisosomes, we investigated the localization of 
Nce102-GFP in pil1(4A) cells. We found it to distribute nor-
mally in both MCCs and the remainder of the plasma membrane 
(Fig. 9 f). When we added myriocin to these cells, eisosomes re-
mained assembled as a result of the pil1(4A) mutation, yet Nce102-
GFP relocalized to become diffusely distributed throughout the 
plasma membrane (Fig. 9 f). To test whether this is a general 
property of MCC proteins, we performed similar experiments 
with cells expressing Sur7-mars. When we treated these cells 
with myriocin, the intensity of Sur7 signal in MCC decreased as 
Pil1 disassembled (Fig. 9 g; not depicted), but this could be com-
pletely blocked by expressing Pil1(4A) (Fig. 9 h). Thus, Nce102-
GFP has a distinct behavior from other MCC components and 
redistributes in the plasma membrane dependent on sphingo-
lipids but independently of the eisosome assembly state.
Discussion
We  report  a  comprehensive  screen  for  genes  involved  in   
Pil1-GFP localization. Recently, a similar screen using an MCC 
reporter identified 27 genes (Grossmann et al., 2008). Compared 
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of their resistance to Triton X-100 detergent extraction. For ex-
ample, the MCP marker Pma1 was also previously used as a 
marker for detergent-resistant lipid rafts (Bagnat et al., 2000; Lee 
et al., 2002; Malinska et al., 2003). The difference in Triton X-100 
solubility between Nce102 and Pma1 after myriocin treatment 
might therefore indicate that these proteins differently partition 
into such lipid rafts or that the MCP is actually more complex 
and contains subdomains not easily resolved by light microscopy. 
Consistent with the later notion, TORC2 (Tor kinase complex 2) 
is localized at a distinct plasma membrane domain separate from 
MCC and MCP and is also partially detergent resistant (Aronova 
et al., 2007; Berchtold and Walther, 2009).
The sensing mechanism of sphingolipids in the plasma 
membrane by Nce102 suggested in this study is different from 
a previous model positing that soluble sphingoid bases in the 
cytoplasm directly control Pkh kinases (Zhang et al., 2004; Liu 
et al., 2005). It is possible that sphingolipids control the activity 
of Pkh kinases at many levels. Sphingoid bases could, for exam-
ple, directly regulate Pkh kinases as in vitro experiments suggest 
(Zhang et al., 2004), and complex sphingolipids could affect 
signaling via Nce102. However, the in vivo effect of direct inhi-
bition of Pkh kinase activity toward Pil1 by sphingoid bases is 
probably minor compared with the Nce102 pathway, as exoge-
nously added PHS was not able to counteract the nce102  
hyperphosphorylation effect on eisosomes.
Our model of regulation of Pkh kinases by complex sphingo-
lipids via the transmembrane protein Nce102 would also bridge 
the topological barrier between the cytoplasmic Pkh kinases and 
complex sphingolipids mainly concentrated in the outer leaflet of 
the plasma membrane (van Meer et al., 2008).
Downstream of sphingolipid sensing, the Nce102–Pkh 
pathway regulates phosphorylation of Pil1 that, when increased, 
always correlated with eisosome disassembly, e.g., in nce102 
cells. This effect could be blocked by mutating phosphorylated 
Pil1 residues to alanines that we previously found were required 
and sufficient for the effect of Pkh kinases on eisosomes (Walther 
et al., 2007). This is different from findings by Luo et al. (2008), 
who reported that a mutant form of Pil1 harboring five phospho-
sites mutated to alanine (S6A, S59A, T233A, S273A, and S299A) 
cannot assemble properly and argued that phosphorylation of Pil1 
synthesis is blocked, Nce102 redistributes away from Pkh ki-
nases (Fig. S5), alleviating their inhibition. Therefore, we pro-
pose a model that Nce102 acts as part of a sphingolipid-sensing 
mechanism and that its distribution in the plasma membrane reg-
ulates Pkh kinases (Fig. 10). In the simplest hypothesis, Nce102 
could simply accomplish repression of the kinases by regulated 
juxtaposition to them, which is a common scheme in kinase sig-
naling. Based on filipin staining, MCCs were suggested as sites 
of increased ergosterol concentration in the plasma membrane 
(Grossmann et al., 2007), and because sterols preferentially   
interact with sphingolipids, it is likely that sphingolipids are also 
concentrated there, forming detergent-resistant, liquid-ordered 
membrane domains or lipid rafts (Simons and Ikonen, 1997;   
Malinska et al., 2003) where Nce102 was found previously (Bagnat 
et al., 2000). Thus, it is possible that Nce102 also reacts to ergos-
terol levels in the plasma membrane. However, we did not ob-
serve an effect of nonessential erg mutants or block of sterol 
synthesis on eisosomes or Nce102 localization (unpublished data). 
Consistent with our model, Nce102 localizes to eisosome rem-
nants that also show increased filipin staining, likely reflecting 
increased concentration of ergosterol and possibly sphingolipids 
(Grossmann et al., 2007). Alternatively, filipin might preferen-
tially report on free sterols not in complex with sphingolipids, 
and staining of MCCs could actually indicate a lower concentra-
tion of sphingolipids in this compartment. This view is supported 
by a recent observation that filipin staining increases if sphingo-
lipid synthesis is blocked (Jin et al., 2008). A further alternative 
is that Nce102 could directly bind sphingolipids, changing its af-
finities to other proteins that help localize it to MCCs and/or 
switching its activity as a Pkh kinase inhibitor on and off. In   
either model, Nce102 leaves the MCC when sphingolipid levels 
there are low, releasing its inhibition of Pkh kinases that now 
phosphorylate Pil1 and other targets. This is consistent with our 
observation that Nce102 detergent solubility changes after inhi-
bition of sphingoid base synthesis, indicating that it partitions 
between  different  membrane  environments.  Most  likely,  this 
change corresponds to the relocalization of Nce102 from MCCs 
to the remainder of the membrane observed by microscopy. The 
interpretation of this result, however, remains vague, as most 
proteins in the yeast plasma membrane differ only in the degree 
Figure  10.  Model  for  Nce102  function  in 
sphingolipid sensing. Nce102 (green) senses 
sphingolipid levels in the plasma membrane 
by distributing between the thick sphingolipid-
rich MCC (blue) and the rest of the plasma 
membrane (gray) depending on sphingolipid 
levels. In the MCC, it inhibits Pkh kinases (red) 
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and to regulate a late step in the synthesis of complex sphingo-
lipids (Tabuchi et al., 2006). It is therefore likely that the TORC2 
and  Pkh1/2  pathways  collaborate  to  regulate  sphingolipid 
metabolism in yeast. Given the similarity of the signaling pathway 
components and its architecture in higher eukaryotes, their out-
put may also be evolutionarily conserved.
Materials and methods
Visual screen
To generate a library of deletion mutants each expressing Pil1-GFP, we 
performed a modification of the synthetic genetic array screen as described 
previously (Tong et al., 2001). In short, a MAT strain containing a chromo-
somal copy of Pil1-GFP marked with a NAT
R marker, the CAN1 gene 
disrupted by a construct that encodes the MATa promoter driving expres-
sion of the HIS3 gene and the LYP1 gene disrupted by a construct express-
ing LEU2 from the MF promoter (KEM108), was crossed to the MATa 
deletion library BY4741 (each strain marked with KAN
R). Diploids were 
selected on G418 and nourseothricin and sporulated. From the sporula-
tion, MATa haploids containing both Pil1-GFP and the deletion gene were 
selected with successive pinning on –HIS (selection for MATa cells), G418 
(selection for the gene deletion from the library), canavanine (selection for 
haploid cells harboring can1), S-(2-aminoethyl)-l-cysteine hydrochloride 
(selection for haploid cells harboring lyp1), and nourseothricin (selection 
for Pil1-GFP)-containing media.
For imaging, cells were grown overnight to saturation in 384-well 
plates, transferred to 96-well plates, diluted, and grown for 9 h until they 
reached  mid-log  phase.  Cells  were  transferred  to  glass-bottom  96-well 
plates coated with concanavalin A and imaged with a 40× high NA objec-
tive in an ImageXPress Micro (MDS Analytical Technologies). At least six 
different images were taken for each deletion strain.
The images were visually inspected using the software by the micro-
scope manufacturer and classified using three categories: increased cyto-
solic  Pil1-GFP  fluorescence,  altered  number  or  eisosomes,  and  altered 
pattern of eisosomes. Strains that showed a phenotype in this first round of 
screening  were  regrown  and  imaged  by  using  a  confocal  microscope 
(LSM510; Carl Zeiss, Inc.).
Two optical mid-section and two top-section images were taken for 
each strain, showing 15–40 cells per image. Images were visually ana-
lyzed, and several parameters of the Pil1-GFP signal on the surface of cells 
were quantitated using an image interpretation script developed in MATLAB 
that  we  named  EISURAN  (both  the  source  code  and  an  executable   
MATLAB  file  can  be  found  at  http://www.biochem.mpg.de/en/rg/ 
walther/news/index.html). In short, EISURAN first subtracts background 
from the images and then finds the edge of a cell by image dilation. To 
facilitate the quantitation of signal from assembled Pil1, the script thresholds 
the image using Otsu’s method (Otsu, 1979). From the resulting binary image, 
EISURAN calculates the number of positive pixels per cell, a measure for 
the area covered by eisosomes (percentage of cell surface covered by 
eisosomes). It then calculates the mean size of the connected clusters (mean 
pixel number per eisosome cluster on cell surface). To eliminate small back-
ground clusters, a minimum of 20 pixels are used for the lower cut off. In 
some conditions, very large values result caused by connection of eiso-
somes into very large clusters, which are sometimes string formed. To de-
termine how much Pil1 is in individual eisosomes, EISURAN determines the 
mean intensity of each cluster by applying the binary image as a mask on 
the original image, integrating the intensity in each cluster, and averaging 
this intensity over all clusters in an image (mean integrated intensity per 
eisosome cluster on cell surface). Quantitation of eisosome number was 
based on the mean number of eisosomes counted by two independent ob-
servers in optical mid sections of mother cells (eisosome number; mean for 
the wild type = 11.5 ± 1.55).
The cytoplasmic signal was quantitated as the mean intensity of 
a 50 × 50–pixel area in the cytoplasm (cytoplasmic Pil1-GFP signal) 
visible in a confocal mid section of the cell using ImageJ (National Institutes 
of Health). The resulting values were averaged from at least 20 cells,   
analyzed by hierarchical clustering, and displayed using R software 
(http://www.r-project.org).
Yeast strains and plasmids
All yeast strains used as well as their genotypes are listed in Table S1. The 
starter strain used for the screen Pil1-GFP::NAT
R (KEM 108) was generated 
in the strain YMS196 (provided by N. Krogan, University of California, 
is important for assembly of eisosomes rather than disassembly. 
In this study, even a mutant that lacks these five sites and even two 
additional sites (S6A, S45A, S59A, S230A, T233A, S273A, and 
S299A) still assembles into eisosomes correctly (unpublished data). 
The reason for this difference is unclear but might indicate that 
additional pathways to the Nce102–Pkh kinase module regulate 
Pil1 phosphorylation in a complex fashion.
Besides phosphorylation of Pil1, Pkh kinases modify many 
plasma membrane functions. Therefore, as expected, nce102 
cells show altered organization of the plasma membrane, as ob-
served for MCCs, MCPs, and the endocytic foci marked by the 
lipophilic dye FM4-64. Recently, it was also shown that nce102 
cells  have  accelerated  endocytosis  rates  of  some  membrane 
transporters (Grossmann et al., 2008). Pkh kinases also partici-
pate in processes as diverse as cortical actin patch organization, 
cell integrity signaling, endocytosis, and eisosome organization 
(Inagaki et al., 1999; Sun et al., 2000; deHart et al., 2002; Roelants 
et al., 2002; Zhang et al., 2004; Liu et al., 2005; Grosshans et al., 
2006; Walther et al., 2007; Luo et al., 2008). Regulation of these 
diverse processes may help control the composition of the plasma 
membrane according to need, perhaps constituting part of a neg-
ative feedback loop that targets genes involved in sphingolipid 
synthesis. Indeed, expression of such genes, e.g., LCB2, FEN1, 
and SUR4, is strongly negatively correlated to the expression of 
NCE102 when the latter is regulated in response to various phys-
iological conditions, e.g., during diauxic shift, nitrogen deple-
tion, or heat shock (correlations for NCE102/SUR4 are: diauxic 
shift, 0.94; nitrogen starvation, 0.66; and heat shock, 0.85; 
Fig. S3, b–d; DeRisi et al., 1997; Gasch et al., 2000). In addition, 
after prolonged incubation with PHS, we observed Nce102-GFP 
signal at the vacuole (unpublished data), perhaps reflecting an 
adaptation to recalibrate the set level of Pkh signaling after long 
times with high sphingolipids levels.
An important role of Nce102 in regulation of sphingo-
lipids is also supported by the ability of its deletion to suppress the 
growth defect of a mutation in the serine palmitoyl transferase 
subunit TSC3 (Schuldiner et al., 2005; unpublished data) or the 
growth inhibition caused by myriocin (Fig. S3 a), both of which 
reduce the first and rate-limiting step in sphingolipid synthesis.
Salient features of the sphingolipid–Nce102–Pkh kinase 
signaling network are likely conserved between yeast and other 
eukaryotes. Nce102 shares homology with the synaptogyrin/
cellugyrin protein family (Belfort et al., 2005), but the molecu-
lar roles of these proteins are not understood. In contrast, mam-
malian PDK1 kinases (the homologues of yeast Pkh kinases) 
are well characterized, and the general architecture of down-
stream signaling is conserved (Casamayor et al., 1999). In   
either system, full activation of AGC kinases, such as AKT, Sch9, 
serum glucocorticoid kinase, or Ypk1/2, requires phosphoryla-
tion both by PDK1 (in mammalian cells) or Pkh kinases (in 
yeast) and in addition by the conserved kinase complex TORC2 
(Powers, 2007). For yeast, TORC2 signaling has been impli-
cated in the regulation of sphingolipid biosynthesis (Beeler et al., 
1998; Tabuchi et al., 2006; Aronova et al., 2008). This effect of 
TORC2 is mediated by the Pkh kinase target Ypk2 (Aronova   
et al., 2008). Additionally, the Slm proteins were identified as 
targets of both the TORC2 and Pkh kinase signaling pathways JCB • VOLUME 185 • NUMBER 7 • 2009   1240
Isolation of detergent-resistant membranes
Detergent-resistant membranes were isolated essentially as described pre-
viously (Bagnat et al., 2000). In brief, 20 ODs Nce102-TAP–expressing 
yeast cells were harvested by centrifugation. The pellets were washed once 
with water and lysed in TNE buffer (50 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, and 5 mM EDTA) by vortexing with glass beads twice for 5 min 
each at 4°C. The lysate was cleared of unbroken cells by centrifugation at 
500 g for 5 min and incubated with Triton X-100 (1% final) for 30 min on 
ice. 250 µl lysate was adjusted to 40% Optiprep by adding 500 µl of 60% 
Optiprep solution and overlaid with 1.2 ml of 30% Optiprep in TXNE (TNE 
and 0.1% Triton X-100) and 200 µl TXNE. The samples were centrifuged 
at 55,000 rpm for 2 h in a rotor (S55S; Sorvall), and five fractions of equal 
volume were collected from the top. Proteins of each fraction were precipi-
tated with 10% trichloroacetic acid for 15 min on ice. Precipitates were re-
suspended in 50 µl 2× sample buffer (0.24 M Tris, pH 8.0, 8% SDS, 1 mM 
DTT, 40% glycerol, and 0.4% bromphenol blue) and heated at 65°C. 25-µl 
aliquots were loaded onto 12% SDS-PAGE gel and analyzed by Western 
blotting. Nce102-TAP was detected with a rabbit peroxidase antiperoxi-
dase antibody (Sigma-Aldrich), Pma1 with a rabbit anti-Pma1 antibody 
(Santa Cruz Biotechnology, Inc.), and a horseradish peroxidase–coupled 
goat anti–rabbit IgG antibody (Santa Cruz Biotechnology, Inc.).
MS
700 ODs of light-labeled PIL1-TAP and heavy-labeled PIL1-TAP nce102 cells 
were harvested by centrifugation resuspended in 5 ml of buffer (150 mM 
KOAc, 20 mM Hepes, pH 7.4, 10% glycerol, and complete protease inhibi-
tor cocktail [Roche]) and phosphatase inhibitor cocktail (Sigma-Aldrich) and 
frozen in liquid nitrogen. Total protein was extracted by bead milling; the 
thawed lysates were incubated with Triton X-100 (1% final) for 30 min at 4°C 
and clarified by two consecutive spins of 4 min at 1,000 g. To immunopurify 
Pil1-TAP, equivalent amounts of the lysates of PIL1-TAP cells and PIL1-TAP 
nce102 cells, according to the protein concentration, were incubated with 
IgG conjugated to agarose beads (GE Healthcare) for 2 h, washed, and 
eluted by TEV cleavage and centrifugation. The eluates were mixed, reduced 
for 20 min at RT in 1 mM DTT, and alkylated for 30 min by 5.5 mM iodo-
acetamide at RT in the dark. Nu-PAGE sample buffer (Invitrogen) was added, 
and the sample was loaded onto 4–12% Nu-PAGE Bis-Tris SDS-PAGE gels 
(Invitrogen). Two Pil1 bands were excised from the gel, and proteins were 
digested with endoproteinase LysC in gel overnight at RT. The resulting 
peptides were extracted with 30% acetonitrile and 3% trifluoroacetic acid, 
reduced in a speed vacuum centrifuge, and desalted and concentrated on 
a reversed-phase column (C18 StageTip; Rappsilber et al., 2003).
In a different approach, the mixed eluates were precipitated with 
chloroform/methanol and resuspended in 8 M urea. Proteins were alkyl-
ated, reduced, and directly digested in solution overnight at RT with LysC. 
Peptides  were  desalted  and  concentrated  on  StageTips.  Peptides  were 
eluted from the StageTips by passage of 2× 20 µl solvent B (80% aceto-
nitrile and 0.5% acetic acid). The volume was reduced to 4 µl in a speed 
vacuum centrifuge, and 2 µl solvent A* (2% acetonitrile and 1% trifluoro-
acetic acid) was added to acidify the sample. Peptides were separated on 
line to the mass spectrometer by using an HPLC system (1200; Agilent 
Technologies). 5-µl samples were loaded with constant flow of 500 nl/min 
onto a 15-cm fused silica emitter with an inner diameter of 75 µm (Proxeon 
Biosystems) packed in house with reverse-phase 3-µm resin (ReproSil-Pur 
C18-AQ; provided by Dr. Maisch GmbH). Peptides were eluted with a 
segmented gradient of 10–60% solvent B over 110 min with a constant 
flow of 250 nl/min. The HPLC system was coupled to a mass spectrometer 
(linear trap quadrupole Orbitrap; Thermo Fisher Scientific) via a nanoscale 
LC interface (Proxeon Biosystems). The spray voltage was set to 2.2 kV, 
and the temperature of the heated capillary was set to 180°C.
The mass spectrometer was operated in positive-ion mode. Survey 
full-scan MS spectra (m/z = 300–1,600) were acquired with a resolution of 
60,000 at m/z = 400 after accumulation of 1,000,000 ions. The most 
intense ions (up to five) from the preview survey scan delivered by the Orbi-
trap  were  sequenced  by  collision-induced  dissociation  (collision  energy 
35%) in the linear trap quadrupole after accumulation of 5,000 ions. Multi-
stage activation was enabled in all MS/MS events to improve fragmentation 
of phosphopeptides. Maximal filling times were 1,000 ms for the full scans 
and 150 ms for the MS/MS. Precursor ion charge state screening was 
enabled, and all unassigned charge states as well as singly charged peptides 
were rejected. The dynamic exclusion list was restricted to a maximum of 
500 entries with a maximum retention period of 90 s and a relative mass 
window of 10 ppm. Orbitrap measurements were performed enabling the 
lock mass option for survey scans to improve mass accuracy (Olsen et al., 
2005). Data were acquired using the Xcalibur software (version 2.0.5).
San Francisco, San Francisco, CA) by tagging Pil1 with GFP using homol-
ogous recombination. Nce102-GFP::HIS and nce102::NAT
R were gener-
ated in the W303 wild-type strain by homologous recombination of 
PCR-generated fragments to yield strains TWY840 and TWY842, respec-
tively (Janke et al., 2004). The pil1:KAN
R NCE102-GFP::HIS was simi-
larly  generated  by  homologous  recombination,  transforming  the 
NCE102-GFP and marker into the pil1 strain TWY226 to yield TWY836. 
Analogously, nce102::NAT
R Pil1-GFP was generated by transforming a 
PIL1-GFP fragment with an HIS marker into TWY842 to yield TWY837. The 
Nce102-TAP:KAN
R strain was generated by homologous recombination 
after transforming an Nce102-TAP fragment in the S288C wild-type strain 
to yield TWY897 (Janke et al., 2004). Strains harboring pkh
ts mutants and 
Pil1-GFP were described previously (Walther et al., 2007). nce102::
NAT
R was generated by homologous recombination of a PCR fragment in 
a control strain with the same background as pkh
ts and used to derive a 
strain with pkh1
ts pkh2::LEU nce102::NAT
R Pil1-GFP::URA by crossing, 
sporulation, and selection of haploid cells to yield strain TWY932. All dele-
tion strains were confirmed by PCR, and strains expressing tagged proteins 
were confirmed by PCR and Western blot analysis.
A pil1::KAN
R nce102::NAT
R strain was generated by crossing 
pil1 strain TWY226 with the nce102 strain TWY841. Sporulation and 
selection yield TWY898.
pRS306 plasmids containing the PIL1 promoter, the wild type, or 
mutated ORF fused to GFP used for expression of phosphomimicking and 
nonphosphorylatable Pil1 were described previously (Walther et al., 
2007) and were integrated into the URA locus of TWY898 to yield 
TWY931 and TWY934.
Pma1-GFP was created by PCR-mediated tagging in wild type or 
nce102::NAT
R to generate TWY958 and TWY1049, respectively. Simi-
larly, SUR7-GFP strains were generated to yield TWY956 (wild type) and 
TWY1049 (nce102).
The pGalNce102-mars plasmid was created by cloning a fusion 
PCR product combining the Gal-promoter, the Nce102 ORF, and the mars 
sequence into the NotI and HindIII sites of pRS306. This plasmid was inte-
grated into the URA3 locus of TWY110 to yield TWY1222.
For SILAC labeling, the lysine auxotroph S288C strain TWY70 was 
transformed  with  a  Pil1-TAP  fragment  to  get  the  Pil1-TAP:KAN
R  strain 
TWY1004 (Janke et al., 2004). To generate a Pil1-TAP:KAN
R nce102:
NAT
R strain, TWY1004 was transformed with a nce102 fragment yield-
ing TWY1052 (Janke et al., 2004).
Yeast culture and drug treatment
Yeast cells were grown according to standard procedure. For microscopy, 
cells were grown in synthetic complete medium and bound to concanavalin 
A–treated coverslips. Myriocin (Sigma-Aldrich) and PHS (Sigma-Aldrich) 
were added in concentrations as indicated and incubated for 1 h or 15 min. 
Cycloheximide (Sigma-Aldrich) was added in a concentration of 100 µg/ml 
for 1 h and 15 min before treatment with other drugs.
For SILAC labeling, Pil1-TAP–expressing yeast cells in a wild-type or 
nce102 background were grown in 1 l YNB liquid medium. PIL1-TAP cells 
were grown in the presence of 20 mg/l normal L-lysine, and PIL1-TAP 
nce102 cells were grown in the presence of 20 mg/l L-lysine-U-
13C6,
15N2 
overnight with at least 10 doublings to OD600 = 0.7.
Microscopy
For fluorescence microscopy, yeast cells were grown to OD = 0.6 in syn-
thetic medium at 30°C unless indicated otherwise. Cells were mounted in 
synthetic media onto coverslips previously coated with concanavalin A and 
directly  imaged  with  a  spinning-disk  confocal  microscope  (TiLL  iMIC 
CSU22; Andoor) using a back-illuminated EM charge-coupled device cam-
era (iXonEM 897; Andor) and a 100× 1.4 NA oil immersion objective 
(Olympus). From this setup, 16-bit images were collected using Image iQ 
(version 1.9; Andor) in the linear range of the camera. For presentation, 
images were filtered with a smoothening filter averaging 2 pixels, con-
verted to 8-bit images, and cropped using ImageJ software (http://rsbweb 
.nih.gov/ij/).
FM4-64 assay
To measure the formation of early FM4-64 uptake intermediates, either 
wild-type or nce102 cells were grown in mid-log phase to OD = 0.5.   
Approximately 5 ml cell culture was harvested by centrifugation and incu-
bated on ice for 5 min. Cells were then labeled for 10 min with 40 µM 
FM4-64, washed three times in ice-cold medium, and resuspended in RT 
YPD for 5 min. Cells were killed by addition of 10 mM NaN3 and NaF 
each and immediately analyzed by fluorescence microscopy.1241 NCE102 MEDIATES SPHINGOLIPID SIGNALING • Fröhlich et al.
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Mass spectra were analyzed using the in house–developed software 
MaxQuant (version 1.0.1; Cox and Mann, 2008). The data were searched 
against the yeast database concatenated with reversed copies of all se-
quences (Moore et al., 2002; Peng et al., 2003) and supplemented with 
frequently observed contaminants (porcine trypsin, Achromobacter lyticus 
lysyl-endopeptidase, and human keratins) using Mascot (version 2.2.0; 
Matrix Science; Perkins et al., 1999).
Carbamidomethylated cysteines were set as fixed, oxidation of 
methionine, N-terminal acetylation and phosphorylation of serines, threonines, 
and tyrosines as variable modification. 0.5 D was set as maximum-allowed 
mass deviation for MS/MS peaks, and a maximum of three missed cleav-
ages were allowed. Maximum false discovery rates were set to 0.01 both 
on peptide and protein levels. Minimum-required peptide length was six 
amino acids. Proteins with at least two peptides (thereof one uniquely as-
signable to the respective sequence) were considered identified.
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Fig. S1 shows a flowchart of the screening process and the quantita-
tion of Pil1-GFP mutant phenotypes. Fig. S2 shows mass spectrometric 
analysis of Pil1 phosphorylation in wild-type and nce102 or myriocin-
treated and -untreated control cells. Fig. S3 shows growth curves of 
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sis gene expression. Fig. S4 shows Nce102-GFP localization depend-
ing on sphingolipids, phosphomimicking Pil1 mutant being enhanced by 
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mutants. Fig. S5 shows colocalization of Pkh2 and Nce102 depending 
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.org/cgi/content/full/jcb.200811081/DC1.
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